Moderna files for full U.S. approval of COVID-19 vaccine
The Peninsula
Moderna Inc said on Tuesday it has started an application for full U.S. approval of its COVID-19 vaccine, which is currently only authorized for emergency use in the country.
The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their COVID-19 vaccine in the United States. Full approval for the vaccines, which are at the forefront of global immunization efforts, could be an important step in allaying vaccine hesitancy, a growing concern in the United States and other wealthy nations.More Related News